3Billion Inc. (394800) Stock Forecast & Analysis
Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for 3Billion Inc. (394800:KRX), powered by AI.
- Current Price
- ₩11,770
- P/E Ratio
- -69.1
- Market Cap
- 373.8B
- Sector
- Healthcare
What is the 3Billion Inc. stock price forecast?
3Billion Inc. is currently trading at ₩11,770. View real-time AI analysis on Alpha Lenz.
What is 3Billion Inc. insider trading activity?
View the latest insider trading data for 3Billion Inc. on Alpha Lenz.
What is 3Billion Inc.'s P/E ratio?
3Billion Inc.'s P/E ratio is -69.1.
3Billion Inc.
KRX · 394800“3Billion Inc. trades at a P/E of -69.1 (undervalued) with modest ROE of -20.9%. 3Y revenue CAGR of 141.8% highlights clear growth momentum.”
Ask for details →Company Overview
3Billion Inc. is a biotechnology company with a focus on developing advanced genomic technologies that aid in the diagnosis and treatment of genetic disorders. The primary function of 3Billion Inc. is to provide comprehensive genetic testing and analysis services aimed at identifying and understanding rare diseases. This company is recognized for its commitment to leveraging cutting-edge technologies such as next-generation sequencing and bioinformatics to deliver precise and reliable diagnostics. Operating within the healthcare and life sciences sectors, 3Billion Inc. plays a crucial role in enhancing personalized medicine, which caters to the specific genetic makeup of individuals. This focus helps healthcare providers offer tailored therapeutic strategies, thus improving patient outcomes. By facilitating early detection and accurate diagnosis, 3Billion Inc. contributes to minimizing healthcare costs and advancing medical research. The company is strategically positioned in the biotechnology landscape to support ongoing innovation and development in personalized health solutions, making it significant in driving forward the precision medicine initiative across the global healthcare sector.
Company Statistics
FY 2025Profile
Margins
Valuation
Growth (CAGR)
Returns
Financial Health
“3Billion Inc. trades at a P/E of -69.1 (undervalued) with modest ROE of -20.9%. 3Y revenue CAGR of 141.8% highlights clear growth momentum.”
Ask for details →Frequently Asked Questions
3Billion Inc. (ticker: 394800) is a company listed on KRX in the Healthcare sector (Biotechnology). Market cap is $373.8B.
The current price is ₩11,770 with a P/E ratio of -69.08x and P/B of 15.84x.
ROE is -20.87% and operating margin is -50.30%. Annual revenue is $11.7B.